HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2014 | $59.7 K |
2015 | --- |
Total: | $59.7 K |
Period | Weight, tons. |
---|---|
2014 | 0.023 |
2015 | --- |
Total: | 0.023 |
Group product | 2014 | 2015 | Ch. | ∑ (2014-2015) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $59.7 K | --- | 100% | $59.7 K | 100% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | --- | --- | --- | --- | 0% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $59.7 K | --- | $59.7 K |
№ | Country | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Turkey | $44.3 M | 73% |
2 | Germany | $8.7 M | 14.3% |
3 | United States | $3.1 M | 5% |
4 | China | $1.4 M | 2.3% |
5 | Italy | $1.2 M | 1.9% |
6 | France | $941 K | 1.6% |
7 | Belarus | $483 K | 0.8% |
8 | Czech Republic | $316 K | 0.5% |
9 | Ukraine | $121 K | 0.2% |
10 | Brazil | $61.4 K | 0.1% |
11 | Ireland | $59.7 K | 0.1% |
12 | Spain | $35.7 K | 0.1% |
13 | Bulgaria | $35.2 K | 0.1% |
14 | United Kingdom | $25.8 K | 0% |
15 | Japan | $10.9 K | 0% |
16 | Poland | $3.7 K | 0% |
17 | Kyrgyzstan | $329 | 0% |
The total for all countries: | $60.7 M | 100% |
№ | Region | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Moskva | $473 M | 98.8% |
2 | Moskovskaya oblast | $4.5 M | 0.9% |
3 | Sankt-Peterburg | $603 K | 0.1% |
4 | Sverdlovskaya oblast | $366 K | 0.1% |
5 | Novosibirskaya oblast | $164 K | 0% |
6 | Samarskaya oblast | $103 K | 0% |
7 | Tatarstan | $59.7 K | 0% |
8 | Leningradskaya oblast | $41.3 K | 0% |
9 | Kirovskaya oblast | $5.2 K | 0% |
10 | Kaliningradskaya oblast | $336 | 0% |
By all regions: | $479 M | 100% |